SeaStar Medical Holding Stock
SeaStar Medical Holding Corporation
Company data
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- CEO
- Eric Schlorff
- Employees
- 18
- Market cap
- $8 M
- IPO
- 18/03/2021
SeaStar Medical Holding Corporation is a medical device company dedicated to providing innovative solutions and services designed to combat hyperinflammation and cytokine storm in critically ill individuals. The company specializes in developing and commercializing extracorporeal therapies that specifically target the…
SeaStar Medical Holding stock: price history
1D
-5.2%
1W
-19.7%
1M
-5.8%
6M
-31.0%
YTD
+20.8%
1Y
-54.0%
2Y
-93.1%
5Y
–
10Y
–
Next earnings date
Next earnings date
12/11/2026 (in 26 days)
Volatility around earnings
~14% stronger price swings than usual
Ask the agents about SeaStar Medical Holding
Analyst assessment of SeaStar Medical Holding
PRICE TARGET LOW
US$8.00
CONSENSUS
US$8.00
MEDIAN
US$8.00
PRICE TARGET HIGH
US$8.00
0
STRONG BUY
1
BUY
0
HOLD
0
SELL
0
STRONG SELL
1
TOTAL · Buy
As of: 14/05/2026
SeaStar Medical Holding stock metrics
P/E
-0.74
P/B
2.76
EV/EBITDA
-0.13
RETURN ON EQUITY
-86.8%
NET MARGIN
-606.5%
DEBT/EQUITY
0
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
99.3%
FLOAT SHARES
2,818,545
AVG. DAILY VOLUME (30D)
166,411
Insider transactions (SEC)
Messinger Michael
Van Heel Kenneth
Neuman John
Baird Jennifer A
Chung Kevin
Institutional holders
Dividends & Stock splits
Comparable stocks
Frequently asked questions about SeaStar Medical Holding stock
What does SeaStar Medical Holding do?
SeaStar Medical Holding Corporation is a company in the Healthcare sector, Biotechnology industry, headquartered in United States.
The CEO is Eric Schlorff, the company employs around 18 people.
The IPO was on 18/03/2021; the stock trades on NASDAQ under the ticker ICU.
What do analysts say about SeaStar Medical Holding stock?
1 analysts rate the stock, the consensus is Buy (as of 14/05/2026).
The average price target is US$8.00, ranging from US$8.00 to US$8.00, with a median of US$8.00.
This is an external assessment, not a statement by Market Jury.
When does SeaStar Medical Holding report next?
The next earnings date is 12/11/2026.
Around past earnings, price swings were roughly 14% stronger than usual.
Does SeaStar Medical Holding pay a dividend?
No, SeaStar Medical Holding currently does not pay a dividend.
Which stocks are comparable to SeaStar Medical Holding?
Comparable stocks include Vertex Pharmaceuticals, Moderna, Regeneron Pharmaceuticals, Revolution Medicines, Incyte, Exelixis, Neurocrine Biosciences and Summit Therapeutics.
How can I get SeaStar Medical Holding stock analyzed?
Clicking "Analyze stock" lets five strategies assess SeaStar Medical Holding against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.